Web of Science Predicts 2016 Nobel Prize Winners
Detection of Gravitational Waves Generated from Black Holes and Cancer Immunotherapy Research among Laureate-Worthy Discoveries
Philadelphia, PA, September 21, 2016 – The Intellectual Property and Science business of Thomson Reuters, the world’s leader in intelligent information for businesses and professionals, today announced its 2016 Citation Laureates.
The annual Citation Laureates study has predicted 39 Nobel Prize winners since 2002. The study mines scientific research citations within the Web of ScienceTM—the premier global search and discovery platform for the sciences, social sciences and arts and humanities—to identify the most influential researchers in chemistry, physics, physiology or medicine, and economics who are likely winners of the Nobel Prize in current or future years.
This year’s noteworthy nominees include physicists Ronald W.P. Drever, Kip S.Thorne and Rainer Weiss for their development of the Laser Interferometer Gravitational-Wave Observatory (LIGO) which made possible the detection of gravitational waves from coalescing black holes. In physiology or medicine, James P. Allison, Jeffrey A. Bluestone and Craig B. Thompson explained how CD28 and CTLA-4 are regulators of T-cell activation, while Gordon J. Freeman, Tasuku Honjo and Arlene H. Sharpe elucidated the function of programmed cell death-1. The discoveries of both groups have advanced cancer chemotherapy. In economics, Olivier J. Blanchard is recognized for valuable contributions to macroeconomics, including determinants of economic fluctuations and employment.
The 2016 Thomson Reuters Web of Science Citation Laureates:
PHYSIOLOGY or MEDICINE
James P. Allison
Jeffrey A. Bluestone
Craig B. Thompson
For explaining how CD28 and CTLA-4 are regulators of T cell activation, modulating immune response
Gordon J. Freeman
Arlene H. Sharpe
For elucidating programmed cell death-1 (PD-1) and its pathway, which has advanced cancer immunotherapy”
Michael N. Hall
David M. Sabatini
Stuart L. Schreiber
For discoveries of the growth regulator Target of Rapamycin (TOR) and the mechanistic Target of Rapamycin (mTOR)
Marvin L. Cohen
For theoretical studies of solid materials, prediction of their properties, and especially for the empirical pseudopotential method
Ronald W.P. Drever
Kip S. Thorne
For the development of the Laser Interferometer Gravitational-Wave Observatory (LIGO) that made possible the detection of gravitational waves
James A. Yorke
For their description of control theory of chaotic systems, the OGY method
George M. Church
For application of CRISPR-cas9 gene editing in mouse and human cells
Dennis Lo Yuk-Ming
For detecting cell-free fetal DNA in maternal plasma, a revolution in noninvasive prenatal testing
For discovering the enhanced permeability and retention (EPR) effect of macromolecular drugs, a key finding for cancer therapeutics
Olivier J. Blanchard
For contributions to macroeconomics, including determinants of economic fluctuations and employment
Edward P. Lazear
For his development of the distinctive field of personnel economics
Marc J. Melitz
For pioneering descriptions of firm heterogeneity and international trade
“Highly-cited papers turn out to be one of the most reliable indicators of world-class research, and provide a glimpse at what research stands the best chance at being recognized with a Nobel Prize,” said Jessica Turner, global head of government and academia, Intellectual Property and Science, Thomson Reuters. “We applaud our 2016 Citation Laureates for their groundbreaking discoveries, and wish them the best this Nobel season and in the future.”
For the second consecutive year, science enthusiasts are invited to weigh-in with their own Nobel Prize predictions by participating in the “People’s Choice” survey for Nobel Prizes, drawn from the Citation Laureates in contention for the Nobel. Individuals who are interested in taking part can visit StateOfInnovation.com to make their picks.
For detailed information on the methodology of this study, the Citation Laureates, and their fields of research and institutional affiliations, visit StateOfInnovation.com. Follow @TR_ScienceWatch and #CitationLaureate on Twitter for up-to-the-minute news on the predictions and deeper insight into their fields of research.
Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial and risk, legal, tax and accounting, intellectual property and science and media markets, powered by the world's most trusted news organization. For more information, visit www.thomsonreuters.com.
In July 2016, the company entered a definitive agreement to sell its Intellectual Property & Science business to Onex Corporation and Baring Private Equity Asia for $3.55 billion. The sale is expected to close before the end of the year following regulatory approvals and satisfaction of other customary closing conditions. The Intellectual Property & Science business provides of comprehensive intellectual property and scientific information, decision support tools and services that enable the lifecycle of innovation for governments, academia, publishers, corporations and law firms to discover, protect and commercialize new ideas and brands.